Megakaryocytic Expansion in Gilteritinib-Treated Acute Myeloid Leukemia Patients Is Associated With AXL Inhibition.

Suknuntha, Kran; Choi, Yoon Jung; Jung, Ho Sun; Majumder, Aditi; Shah, Sujal; Slukvin, Igor; Ranheim, Erik A

Suknuntha, Kran; Choi, Yoon Jung; Jung, Ho Sun; Majumder, Aditi; Shah, Sujal; Slukvin, Igor; Ranheim, Erik A.

Afiliación

Suknuntha K; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States.
Choi YJ; Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI, United States.
Jung HS; Chakri Naruebodindra Medical Institute, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
Majumder A; Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI, United States.
Shah S; Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI, United States.
Slukvin I; Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI, United States.
Ranheim EA; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, WI, United States.

Front Oncol ; 10: 585151, 2020.

Article en En | MEDLINE | ID: mdl-33363015

Palabras clave

AMLacute myeloid leukemia; AXL; Flt3; gilteritinib (Xospata); internal tandem duplication (ITD); megakaryocyte; midostaurin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google